Ian Chau
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 341
- Colorectal Cancer Treatments and Studies 179
- Cancer Immunotherapy and Biomarkers 61
- Colorectal Cancer Surgical Treatments 58
- Pancreatic and Hepatic Oncology Research 54
- Co-authors
- David CunninghamChris VerslypeEric Van CutsemSalvatore SienaDavid KhayatM. MueserA. HarstrickArmando Santoro
- Journals
- Journal of Clinical Oncology (137 papers)Annals of Oncology (76 papers)British Journal of Cancer (20 papers)European Journal of Cancer (17 papers)Clinical Colorectal Cancer (14 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Ian Chau
442 papers receiving 18.4k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 13.1k
- Hepatology 3.2k
- Pulmonary and Respiratory Medicine 7.2k
- Gastroenterology 1.2k
- Cancer Research 2.4k
Countries citing papers authored by Ian Chau
This map shows the geographic impact of Ian Chau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Chau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Chau more than expected).
Fields of papers citing papers by Ian Chau
This network shows the impact of papers produced by Ian Chau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Chau. The network helps show where Ian Chau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian Chau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 4 | |
| 9 | Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study Hit paper breakdown → | 2023 | 124 |
| 10 | 2021 | 57 | |
| 11 | 2021 | 24 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 86 | |
| 14 | 2019 | 91 | |
| 15 | 2019 | 58 | |
| 16 | 2018 | 11 | |
| 17 | 2017 | 1 | |
| 18 | 2017 | 1 | |
| 19 | TP53 status may predict benefit from cetuximab in high-risk, locally advanced rectal cancer: Results of the EXPERT-C trial | 2013 | 5 |
| 20 | 2012 | 287 |
About Ian Chau
Ian Chau is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Hepatology and Pathology and Forensic Medicine, having authored 473 papers that have together received 18.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (184 papers), Colorectal Cancer Treatments and Studies (179 papers), Esophageal Cancer Research and Treatment (85 papers), Colorectal and Anal Carcinomas (66 papers), Cancer Immunotherapy and Biomarkers (61 papers), Colorectal Cancer Surgical Treatments (58 papers), Pancreatic and Hepatic Oncology Research (54 papers) and Hepatocellular Carcinoma Treatment and Prognosis (47 papers). The work is most often cited by research in Oncology (13.1k citations), Hepatology (3.2k citations), Pulmonary and Respiratory Medicine (7.2k citations), Gastroenterology (1.2k citations) and Cancer Research (2.4k citations). Ian Chau has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include David Cunningham, Chris Verslype, Eric Van Cutsem, Salvatore Siena, David Khayat, M. Mueser, A. Harstrick, Armando Santoro, Harry Bleiberg and Yves Humblet. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.